Faheem Hasnain
President & CEO at Gossamer Bio Inc.
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Gossamer Bio Inc., 3 years.
Gossamer Bio Inc.
Director · President & CEO
Kura Oncology Inc.
Director
Chief executive roles
Gossamer Bio Inc.
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Gossamer Bio Inc. | Grant or award | +280,000 | — | — |
| Dec 9, 2025 | Kura Oncology Inc. | Option exercise | +10,000 | $3.12 | $31,200 |
| Dec 9, 2025 | Kura Oncology Inc. | Open-market sale | −10,000 | $10.98 | $109,800 |
| Oct 1, 2025 | Gossamer Bio Inc. | Grant or award | +437,500 | — | — |
| Mar 21, 2025 | Kura Oncology Inc. | Option exercise | +22,682 | $6.32 | $143,350 |
| Mar 21, 2025 | Kura Oncology Inc. | Open-market sale | −22,682 | $8.00 | $181,456 |
| Jun 21, 2024 | Gossamer Bio Inc. | Open-market purchase | +372,000 | $0.67 | $249,240 |
| Mar 27, 2024 | Gossamer Bio Inc. | Open-market sale | −23,172 | $1.16 | $26,880 |
| Jul 24, 2023 | Gossamer Bio Inc. | Grant or award | +540,176 | $1.82 | $983,120 |
| Mar 22, 2023 | Gossamer Bio Inc. | Open-market purchase | +440,500 | $1.14 | $502,170 |
| Mar 21, 2023 | Gossamer Bio Inc. | Open-market purchase | +269,389 | $1.20 | $323,267 |
| Mar 20, 2023 | Gossamer Bio Inc. | Open-market purchase | +168,683 | $1.03 | $173,743 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.